Prothena
PRTA · NASDAQ
$8.50+$0.02 (+0.24%)TodayMarket closed ·
Prev close $8.48
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 64.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.3988 | -$0.36 | +9.7% |
| Q1 FY26 | -$0.3553 | $0.61 | +271.7% |
| Q4 FY25 | -$0.57 | -$0.40 | +29.8% |
| Q3 FY25 | -$0.7009 | -$0.68 | +3.0% |
| Q2 FY25 | -$1.34 | -$1.73 | −28.9% |
| Q1 FY25 | -$0.9928 | -$1.12 | −12.8% |
| Q4 FY24 | -$1.06 | -$1.08 | −1.6% |
| Q3 FY24 | -$1.20 | -$1.10 | +8.4% |
Earnings calls
- PRTA - Earnings call Q4 2025
- Evercore 8th Annual Healthcare Conference
- PRTA - Earnings call Q4 2024
- PRTA - Earnings call 4 2023
- Morgan Stanley 21st Annual Global Healthcare Conference 2023
- Bank of America Securities 2023 Healthcare Conference
- Earnings call Q4 2022
- Morgan Stanley 20th Annual Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.